Related Experiment Video
Updated: Dec 24, 2025

In Vitro SUMOylation Assay to Study SUMO E3 Ligase Activity
Published on: January 29, 2018
Role of SUMOylation in Human Oncogenic Herpesvirus Infection
Yulin Zhang1, Yuyan Wang1, Caixia Zhu1
1MOE& NHC&CAMS Key Laboratory of Medical Molecular Virology, Department of Medical Microbiology and Parasitology, School of Basic Medicine, Shanghai Medical College, Fudan University, Shanghai 200032, P.R. China.
Abstract:
Post-translational modification of target proteins by the Small Ubiquitin-like Modifier (SUMO) plays a critical role in regulation of many cellular processes including transcription, RNA processing, protein trafficking, DNA repair, and chromosome segregation, and is also often hijacked by viral infections. Epstein-Barr Virus (EBV) and Kaposi's sarcoma-associated Herpesvirus (KSHV), two human oncogenic herpesviruses with a typical life cycle of latent and lytic replication, have been shown to be associated with many human cancers. In the past decade, intensive studies have investigated the interplay between tumor virus infection and SUMO-modification. In this review, we summarize the current knowledge as to how SUMOylation can regulate latent and lytic replication of EBV and KSHV, and the strategies by which these oncogenic herpesviruses usurp the SUMO pathways to establish a favorable microenvironment to promote host cell survival and proliferation in latency, and reactivate virion production during lytic replication, which are critical contributors to the development of EBV/KSHV-associated human malignancies.
Insights
Small Ubiquitin-like Modifier (SUMO)ylation regulates key cellular processes and is exploited by oncogenic herpesviruses like Epstein-Barr Virus (EBV) and Kaposi's sarcoma-associated Herpesvirus (KSHV). This review details how these viruses manipulate SUMO pathways for replication and cancer development.
Area of Science:
- Molecular Biology
- Virology
- Oncology
Background:
- Post-translational modification by Small Ubiquitin-like Modifier (SUMO) is crucial for cellular functions like transcription, DNA repair, and chromosome segregation.
- Oncogenic human herpesviruses, Epstein-Barr Virus (EBV) and Kaposi's sarcoma-associated Herpesvirus (KSHV), are linked to numerous human cancers.
- The interaction between tumor viruses and SUMOylation has been a focus of recent research.
Purpose of the Study:
- To review the current understanding of how SUMOylation influences the latent and lytic replication of EBV and KSHV.
- To elucidate the mechanisms by which EBV and KSHV hijack SUMO pathways.
- To highlight the role of these viral strategies in promoting host cell survival, proliferation, and virion production, contributing to cancer development.
Main Methods:
- Literature review of studies investigating SUMOylation in EBV and KSHV infection.
- Analysis of research on viral manipulation of host SUMO pathways.
- Synthesis of findings related to SUMOylation's role in viral latency and lytic replication.
Main Results:
- SUMOylation regulates both latent and lytic replication cycles of EBV and KSHV.
- These oncogenic viruses employ sophisticated strategies to usurp host SUMO pathways.
- Viral hijacking of SUMOylation promotes a cellular microenvironment conducive to host cell survival and proliferation during latency.
- SUMOylation modulation is critical for reactivating virion production during the lytic phase.
Conclusions:
- SUMOylation is a key regulatory mechanism exploited by EBV and KSHV.
- Understanding the interplay between SUMOylation and these viruses is vital for comprehending EBV/KSHV-associated malignancies.
- Targeting viral manipulation of SUMO pathways may offer therapeutic strategies against these cancers.
More Related Videos
Related Concept Videos
Rous Sarcoma Virus (RSV) and Cancer
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
Conservative Site-specific Recombination and Phase Variation
The recognition sites for Cre recombinase called LoxP...
Mechanisms of Retrovirus-induced Cancers
Abnormal Proliferation
Viruses with RNA Genomes
Leaky Scanning

